- Our Story
- Our Products
- Our Science
- Our People & Citizenship
- 
                                                    
                                                        Investors
                                                    
                                                    
                                                    - Reports and Filings
- Presentations & Earnings Calls
- 
                                                                    Shares
                                                                    
                                                                    - Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Details of Shares for transfer to IEPF May 2021
- Notice pursuant to IEPF Rules, May 2021
 
- Governance
- Investor Services
- 
                                                                    ESG profile
                                                                    
                                                                    
 
- Media
- Partners
- Contact Us
Dr. Reddy's in the news
- 
								
                                The Long-Term RxIf indian pharma's frontline leaders are not looking good, consider it as a short-term bottomline blip. With smart partnerships, b product pipelines and a tight control on costs, the future is definitely not break. Click Here for the Complete Story [PDF Format]
- 
								
                                The Other Disease Plaguing AsiaAvian flu may get the headlines, but the health risks from diabetes are more severe. Help may come from India's and China's pharmas Click Here for the Complete Story [PDF Format]
- 
								
                                Drugs that talkDr. Reddy's Labs signs another innovative deal, this time for discovery and development Click Here for the Complete Story [PDF Format]
- 
								
                                Pillar to successhis year Dr Reddy's Laboratories completes five years of its Chinese Joint venture operations, Kunsham Rotam Reddy Pharmaceutical Co Limited (KRRP). Click Here for the Complete Story [PDF Format]
- 
								
                                Imitiate gives way to InnovateIndia's pharmaceutical industry increasingly turning to research Click Here for the Complete Story [PDF Format]
- 
								
                                Riding Out OfThings are looking up at Dr Reddy's Labs. First quarter profits are up and the stock has gained some of the lost ground . Finally, the worst may be behind the pharma major. Click Here for the Complete Story [PDF Format]
- 
								
                                Search EnginesGV Prasad, Executive Vice Chairman and CEO, Dr. Reddy’s Laboratories, shares his thoughts on the company's 'Globalisation Journey Click Here for the Complete Story [PDF Format]
- 
								
                                Portal of HopeIn the six years since it was set up, Dr. Reddy's Foundations' Livelihood Advancement Business School has helped prepare some 35,000 underpriviledged youngsters for entry-level jobs. Click Here for the Complete Story [PDF Format]
- 
								
                                The Future of Medicine25 CEOs and Thought Leaders on India in the year 2020 Click Here for the Complete Story [PDF Format]
- 
								
                                India Inc: Going GlobalCEOs from leading Indian companies shares their views. Click Here for the Complete Story [PDF Format]

